Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation. - Winterstein AG; Ewig CLY; Wang Y; Smolinski NE; Toyserkani GA; LaCivita C; Lackey L; Eggers S; Zhou EH; Diaby V; Sarayani A; Thai T; et al. (Drug safety, 2025)